- Home
- TOPS vs ANVS Comparison
TOPS vs ANVS Comparison
Compare TOPS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- ANVS
- Stock Information
- Founded
- TOPS 2000
- ANVS 2008
- Country
- TOPS Greece
- ANVS United States
- Employees
- TOPS N/A
- ANVS N/A
- Industry
- TOPS Marine Transportation
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- TOPS Consumer Discretionary
- ANVS Health Care
- Exchange
- TOPS Nasdaq
- ANVS Nasdaq
- Market Cap
- TOPS 28.3M
- ANVS 31.2M
- IPO Year
- TOPS 2004
- ANVS 2020
- Fundamental
- Price
- TOPS $6.46
- ANVS $1.58
- Analyst Decision
- TOPS
- ANVS Strong Buy
- Analyst Count
- TOPS 0
- ANVS 5
- Target Price
- TOPS N/A
- ANVS $37.00
- AVG Volume (30 Days)
- TOPS 8.7K
- ANVS 259.9K
- Earning Date
- TOPS 04-15-2025
- ANVS 05-12-2025
- Dividend Yield
- TOPS N/A
- ANVS N/A
- EPS Growth
- TOPS N/A
- ANVS N/A
- EPS
- TOPS N/A
- ANVS N/A
- Revenue
- TOPS $83,870,000.00
- ANVS N/A
- Revenue This Year
- TOPS $7.10
- ANVS N/A
- Revenue Next Year
- TOPS $6.54
- ANVS N/A
- P/E Ratio
- TOPS N/A
- ANVS N/A
- Revenue Growth
- TOPS 1.10
- ANVS N/A
- 52 Week Low
- TOPS $5.30
- ANVS $1.43
- 52 Week High
- TOPS $14.24
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- TOPS 63.70
- ANVS 35.70
- Support Level
- TOPS $6.33
- ANVS $1.43
- Resistance Level
- TOPS $6.54
- ANVS $2.07
- Average True Range (ATR)
- TOPS 0.19
- ANVS 0.15
- MACD
- TOPS 0.05
- ANVS 0.04
- Stochastic Oscillator
- TOPS 74.47
- ANVS 23.44
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.